Sex and BMI Alter the Benefits and Risks of Sulfonylureas and Thiazolidinediones in Type 2 Diabetes: A Framework for Evaluating Stratification Using Routine Clinical and Individual Trial Data. (2018)
Attributed to:
MICA: MRC APBI STratification and Extreme Response Mechanism IN Diabetes - MASTERMIND
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.2337/dc18-0344
PubMed Identifier: 30072404
Publication URI: http://europepmc.org/abstract/MED/30072404
Type: Journal Article/Review
Volume: 41
Parent Publication: Diabetes care
Issue: 9
ISSN: 0149-5992